Aehr Test Systems R&D Spending Growth & History (AEHR)
Aehr Test Systems's r&d spending was $12.6M for fiscal 2026.
View full Aehr Test Systems company overviewAehr Test Systems annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-05-29 | $12.6M | $2.2M | +20.74% |
| 2025 | 2025-05-30 | $10.5M | $1.7M | +20.00% |
| 2024 | 2024-05-31 | $8.7M | $1.6M | +22.22% |
| 2023 | 2023-05-31 | $7.1M | $1.3M | +22.62% |
| 2022 | 2022-05-31 | $5.8M | $2.2M | +59.31% |
| 2021 | 2021-05-31 | $3.7M | $266,000 | +7.86% |
| 2020 | 2020-05-31 | $3.4M | −$767,000 | −18.47% |
| 2019 | 2019-05-31 | $4.2M | −$28,000 | −0.67% |
| 2018 | 2018-05-31 | $4.2M | −$476,000 | −10.22% |
| 2017 | 2017-05-31 | $4.7M | $333,000 | +7.70% |
| 2016 | 2016-05-31 | $4.3M | $262,000 | +6.45% |
| 2015 | 2015-05-31 | $4.1M | $660,000 | +19.40% |
| 2014 | 2014-05-31 | $3.4M | $191,000 | +5.95% |
| 2013 | 2013-05-31 | $3.2M | −$977,000 | −23.33% |
| 2012 | 2012-05-31 | $4.2M | −$379,000 | −8.30% |
| 2011 | 2011-05-31 | $4.6M | −$191,000 | −4.01% |
| 2010 | 2010-05-31 | $4.8M | — | — |
Aehr Test Systems quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-05-29 | $3.6M | $959,000 | +35.70% |
| Q3 2026 | 2026-02-27 | $3.2M | $27,000 | +0.86% |
| Q2 2026 | 2025-11-28 | $3.0M | $696,000 | +30.58% |
| Q1 2026 | 2025-08-29 | $2.8M | $488,000 | +20.67% |
| Q4 2025 | 2025-05-30 | $2.7M | — | — |
| Q3 2025 | 2025-02-28 | $3.1M | $1.0M | +46.80% |
| Q2 2025 | 2024-11-29 | $2.3M | $304,000 | +15.42% |
| Q1 2025 · Aug 30 | 2024-08-30 | $2.4M | −$96,000 | −3.91% |
| Q3 2024 · Feb 29 | 2024-02-29 | $2.1M | $307,000 | +16.76% |
| Q2 2024 | 2023-11-30 | $2.0M | $421,000 | +27.14% |
| Q1 2024 · Aug 31 | 2023-08-31 | $2.5M | $959,000 | +64.02% |
| Q4 2023 | 2023-05-31 | $2.3M | $598,000 | +36.13% |
| Q3 2023 | 2023-02-28 | $1.8M | $303,000 | +19.82% |
| Q2 2023 | 2022-11-30 | $1.6M | $238,000 | +18.13% |
| Q1 2023 | 2022-08-31 | $1.5M | $177,000 | +13.40% |
| Q4 2022 | 2022-05-31 | $1.7M | $626,000 | +60.84% |
| Q3 2022 | 2022-02-28 | $1.5M | $626,000 | +69.32% |
| Q2 2022 | 2021-11-30 | $1.3M | $493,000 | +60.12% |
| Q1 2022 | 2021-08-31 | $1.3M | $421,000 | +46.78% |
| Q4 2021 | 2021-05-31 | $1.0M | $175,000 | +20.49% |
| Q3 2021 | 2021-02-28 | $903,000 | $58,000 | +6.86% |
| Q2 2021 | 2020-11-30 | $820,000 | $25,000 | +3.14% |
| Q1 2021 | 2020-08-31 | $900,000 | $8,000 | +0.90% |
| Q4 2020 | 2020-05-31 | $854,000 | −$266,000 | −23.75% |
| Q3 2020 | 2020-02-29 | $845,000 | −$86,000 | −9.24% |
| Q2 2020 | 2019-11-30 | $795,000 | −$191,000 | −19.37% |
| Q1 2020 | 2019-08-31 | $892,000 | −$224,000 | −20.07% |
| Q4 2019 | 2019-05-31 | $1.1M | $24,000 | +2.19% |
| Q3 2019 | 2019-02-28 | $931,000 | −$109,000 | −10.48% |
| Q2 2019 | 2018-11-30 | $986,000 | −$104,000 | −9.54% |
| Q1 2019 | 2018-08-31 | $1.1M | $161,000 | +16.86% |
| Q4 2018 | 2018-05-31 | $1.1M | −$213,000 | −16.27% |
| Q3 2018 | 2018-02-28 | $1.0M | −$208,000 | −16.67% |
| Q2 2018 | 2017-11-30 | $1.1M | $50,000 | +4.81% |
| Q1 2018 | 2017-08-31 | $955,000 | −$105,000 | −9.91% |
| Q4 2017 | 2017-05-31 | $1.3M | $263,000 | +25.14% |
| Q3 2017 | 2017-02-28 | $1.2M | −$45,000 | −3.48% |
| Q2 2017 | 2016-11-30 | $1.0M | $117,000 | +12.68% |
| Q1 2017 | 2016-08-31 | $1.1M | −$2,000 | −0.19% |
| Q4 2016 | 2016-05-31 | $1.0M | $79,000 | +8.17% |
| Q3 2016 | 2016-02-29 | $1.3M | $262,000 | +25.41% |
| Q2 2016 | 2015-11-30 | $923,000 | −$182,000 | −16.47% |
| Q1 2016 | 2015-08-31 | $1.1M | $103,000 | +10.74% |
| Q4 2015 | 2015-05-31 | $967,000 | −$49,000 | −4.82% |
| Q3 2015 | 2015-02-28 | $1.0M | $124,000 | +13.67% |
| Q2 2015 | 2014-11-30 | $1.1M | $307,000 | +38.47% |
| Q1 2015 | 2014-08-31 | $959,000 | $278,000 | +40.82% |
| Q4 2014 | 2014-05-31 | $1.0M | $382,000 | +60.25% |
| Q3 2014 | 2014-02-28 | $907,000 | $222,000 | +32.41% |
| Q2 2014 | 2013-11-30 | $798,000 | −$164,000 | −17.05% |
| Q1 2014 | 2013-08-31 | $681,000 | −$249,000 | −26.77% |
| Q4 2013 | 2013-05-31 | $634,000 | −$500,000 | −44.09% |
| Q3 2013 | 2013-02-28 | $685,000 | −$248,000 | −26.58% |
| Q2 2013 | 2012-11-30 | $962,000 | −$77,000 | −7.41% |
| Q1 2013 | 2012-08-31 | $930,000 | −$152,000 | −14.05% |
| Q4 2012 | 2012-05-31 | $1.1M | −$56,000 | −4.71% |
| Q3 2012 | 2012-02-29 | $933,000 | −$106,000 | −10.20% |
| Q2 2012 | 2011-11-30 | $1.0M | −$157,000 | −13.13% |
| Q1 2012 | 2011-08-31 | $1.1M | −$60,000 | −5.25% |
| Q4 2011 | 2011-05-31 | $1.2M | — | — |
| Q3 2011 | 2011-02-28 | $1.0M | — | — |
| Q2 2011 | 2010-11-30 | $1.2M | — | — |
| Q1 2011 | 2010-08-31 | $1.1M | — | — |
Aehr Test Systems r&d spending trends
Over the last five fiscal years, Aehr Test Systems's r&d spending increased from $3.7M to $12.6M, a change of $9.0M. The latest reported quarter, Q4 2026, shows $3.6M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aehr Test Systems source filings ↗